Witte M H, Witte C L
Department of Surgery, University of Arizona College of Medicine, Tucson.
Lymphology. 1987 Dec;20(4):257-66.
The past 15 years have witnessed an explosion of knowledge about blood vascular endothelium due in large part to in vitro growth of endothelial cells from both large blood vessels and capillaries. In contrast, little comparable information has accumulated on endothelium of lymphatics, which lie in intimate contact with parenchymal cells and drain excess fluid, macromolecules, particles, and immunocompetent cells in a continuous recirculation between tissues and bloodstream. While structural and functional differences between the two vascular systems have been described in vivo, in tissue sections, and in isolated preparations, similarities are notable in ultra-structure, biochemistry, physiology, and pharmacologic responsiveness, and these may predominate under pathologic conditions. In 1984, three separate groups described in vitro culture of lymphatic endothelial cells from collecting ducts and cavernous lymphangiomas. Lymphatic, like blood vascular, endothelium grows in confluent monolayers, "sprouts", synthesizes Factor VIII-associated antigen and fibronectin, and ultrastructurally shows Weibel-Palade bodies; overlapping intercellular junctions and anchoring filaments typical of lymphatic endothelium are also found. Genetic, congenital, and acquired disorders such as strangulating fetal nuchal cystic hygromas (Down and Turner syndromes), vascular tumors and dysmorphogenesis (Maffucci and Klippel-Trenaunay syndromes), Kaposi's sarcoma, lymphogenous and hematogenous spread of cancer, and parasitic infestations such as filariasis, share overlapping abnormalities in formation, growth, and/or neoplasia of lymphatics and blood vessels. In these and similar clinical disorders, confusion often exists as to the nature of the cell or tissue of origin, and insight into the role and control of hemangiogenesis and lymphangiogenesis is still in its infancy. Nonetheless, with the ever widening array of investigative techniques, it is not only timely but imperative to explore the endothelial biology underlying these inborn and acquired disorders.
在过去15年里,人们对血管内皮的认识有了极大的飞跃,这在很大程度上归功于从大血管和毛细血管中体外培养内皮细胞。相比之下,关于淋巴管内皮的类似信息积累较少,淋巴管内皮与实质细胞紧密接触,在组织和血液之间持续循环,引流多余的液体、大分子、颗粒和免疫活性细胞。虽然这两种血管系统在体内、组织切片和分离制剂中的结构和功能差异已有描述,但在超微结构、生物化学、生理学和药理反应性方面存在显著相似性,这些相似性在病理条件下可能占主导地位。1984年,三个独立的研究小组描述了从集合管和海绵状淋巴管瘤中体外培养淋巴管内皮细胞的方法。淋巴管内皮与血管内皮一样,以汇合的单层生长,“发芽”,合成因子VIII相关抗原和纤连蛋白,超微结构显示有魏-帕小体;还发现了典型的淋巴管内皮重叠的细胞间连接和锚定丝。遗传、先天性和后天性疾病,如绞窄性胎儿颈部囊状水瘤(唐氏和特纳综合征)、血管肿瘤和畸形发生(马富西和克-特综合征)、卡波西肉瘤、癌症的淋巴源性和血源性扩散以及寄生虫感染(如丝虫病),在淋巴管和血管的形成、生长和/或肿瘤形成方面存在重叠异常。在这些以及类似的临床疾病中,对于起源细胞或组织的性质常常存在混淆,对血管生成和淋巴管生成的作用及调控的认识仍处于起步阶段。尽管如此,随着研究技术的不断扩展,探索这些先天性和后天性疾病背后的内皮生物学不仅适时而且势在必行。